Skip Navigation
Skip to contents

Epidemiol Health : Epidemiology and Health

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
2 "Disease progression"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Brief Communication
Epidemiological evidences on overdiagnosis of prostate and kidney cancers in Korean
Jong-Myon Bae
Epidemiol Health. 2015;37:e2015015.   Published online March 7, 2015
DOI: https://doi.org/10.4178/epih/e2015015
  • 19,048 View
  • 164 Download
  • 7 Web of Science
  • 10 Crossref
AbstractAbstract AbstractSummary PDFSupplementary Material
Abstract
OBJECTIVES
The prostate specific antigen test is widely used as the main method of screening prostate cancer in Korea. Additionally, the use of ultrasound sonography may lead to overdiagnosis of kidney cancer as well as thyroid cancer. This study aimed to highlight epidemiological evidences regarding overdiagnosis of prostate and kidney cancers in Korean.
METHODS
The annual trends of national incidence and mortality of prostate and kidney cancers provided by the Korean Statistical Information Service were evaluated.
RESULTS
The rate of increase in the incidence of prostate and kidney cancer was 6 and 5 times higher than that of mortality between 2000 and 2011, respectively. Additionally, the age group showing the highest incidence in prostate cancer shifted from 85 years and older to 75-79 years.
CONCLUSIONS
This evidence suggests that prostate and kidney cancers are overdiagnosed in Korea. Further research in this area, using national cancer registry databases, should be encouraged to prevent overdiagnosis.
Summary
Korean summary
갑상선암의 과진단은 목초음파검사의 시행에 따른 것이란 주장에 따라, 전립선암과 신장암은 각각 전립선특이항원검사와 복부초음파검사의 시행에 따라 과진단이 있을 것으로 예상된다. 과진단의 여부는 검사 시행 이후 발생률이 증가하는 반면, 사망률은 변동이 없는 것으로 판단할 수 있다. 통계청의 해당 암 발생률과 사망률 추이를 살펴볼 때, 국내에서도 전립선암과 신장암에서 과진단이 있음을 확인할 수 있었다.

Citations

Citations to this article as recorded by  
  • Twenty-two-year incidence trend of urological cancers in the Republic of Korea: 1999–2020
    Seunghyeon Cho, Won-Ju Park
    Investigative and Clinical Urology.2024; 65(1): 23.     CrossRef
  • What is the relationship between the local population change and cancer incidence in patients with dyslipidemia: Evidence of the impact of local extinction in Korea
    Wonjeong Jeong, Dong‐Woo Choi, Woorim Kim, Kyu‐Tae Han
    Cancer Medicine.2024;[Epub]     CrossRef
  • A single-center long-term experience of active surveillance for prostate cancer: 15 years of follow-up
    Sang Hun Song, Jung Kwon Kim, Hakmin Lee, Sangchul Lee, Sung Kyu Hong, Seok-Soo Byun
    Investigative and Clinical Urology.2021; 62(1): 32.     CrossRef
  • Risk of thyroid as a first or second primary cancer. A population‐based study in Italy, 1998–2012
    Emanuele Crocetti, Veronica Mattioli, Carlotta Buzzoni, Silvia Franceschi, Diego Serraino, Salvatore Vaccarella, Stefano Ferretti, Susanna Busco, Ugo Fedeli, Massimo Varvarà, Fabio Falcini, Manuel Zorzi, Giuliano Carrozzi, Walter Mazzucco, Cinzia Gasparot
    Cancer Medicine.2021; 10(19): 6855.     CrossRef
  • Cancer Incidence by Occupation in Korea: Longitudinal Analysis of a Nationwide Cohort
    Hye-Eun Lee, Masayoshi Zaitsu, Eun-A Kim, Ichiro Kawachi
    Safety and Health at Work.2020; 11(1): 41.     CrossRef
  • The Overdiagnosis of Kidney Cancer in Koreans and the Active Surveillance on Small Renal Mass
    Byung Hoon Chi, In Ho Chang
    The Korean Journal of Urological Oncology.2018; 16(1): 15.     CrossRef
  • Potential Epigenetic Biomarkers for Prostate Cancer Screening
    Jong-Myon Bae
    International Neurourology Journal.2018; 22(2): 142.     CrossRef
  • Strategies for Appropriate Patient-centered Care to Decrease the Nationwide Cost of Cancers in Korea
    Jong-Myon Bae
    Journal of Preventive Medicine and Public Health.2017; 50(4): 217.     CrossRef
  • It needs adaptation to the 2015 Korean guideline for breast cancer screening
    Jong-Myon Bae
    Journal of the Korean Medical Association.2015; 58(9): 833.     CrossRef
  • Two different views of interpreting the related evidences on the reply to reader's letter
    Jong-Myon Bae
    Journal of the Korean Medical Association.2015; 58(12): 1196.     CrossRef
Methods
Overdiagnosis: epidemiologic concepts and estimation
Jong-Myon Bae
Epidemiol Health. 2015;37:e2015004.   Published online February 10, 2015
DOI: https://doi.org/10.4178/epih/e2015004
  • 24,050 View
  • 239 Download
  • 16 Web of Science
  • 17 Crossref
AbstractAbstract AbstractSummary PDFSupplementary Material
Abstract
Overdiagnosis of thyroid cancer was propounded regarding the rapidly increasing incidence in South Korea. Overdiagnosis is defined as ‘the detection of cancers that would never have been found were it not for the screening test’, and may be an extreme form of lead bias due to indolent cancers, as is inevitable when conducting a cancer screening programme. Because it is solely an epidemiological concept, it can be estimated indirectly by phenomena such as a lack of compensatory drop in post-screening periods, or discrepancies between incidence and mortality. The erstwhile trials for quantifying the overdiagnosis in screening mammography were reviewed in order to secure the data needed to establish its prevalence in South Korea.
Summary
Korean summary
최근 갑상선암의 발생 증가는 과진단에 기인한 것이란 주장이 제기되었다. 과진단은 ‘평생동안 몰랐을 암을 검진으로 알아낸 경우’로 정의하는 바, 예상보다 늦은 진행으로 예후가 더 좋고 치료를 안해도 사망률 변동을 만들지 못하는 암에 대하여 반복되는 암검진에 더 잘 진단되는 기간차이 바이어스가 개입되는 것을 제대로 통제하지 못해서 생긴 것이다. 검진을 더 이상 하지 않았을 경우 발생률이 본래대로 되돌아오지 않는 현상을 보이거나, 사망률과 발생률 간의 변동에서 큰 차이를 보일 때 과진단이 있다고 판단한다. 국내에서 발생하는 과진단의 크기를 측정하기 위한 방법들을 알아보기 위하여, 기존의 유방암 조기검진용 유방촬영술에 대한 과진단 크기를 알아낸 연구방법들을 살펴보았다.

Citations

Citations to this article as recorded by  
  • Impact of annual trend volume of low-dose computed tomography for lung cancer screening on overdiagnosis, overmanagement, and gender disparities
    Chen Hsin-Hung, Tang En-Kuei, Wu Yun-Ju, Wu Fu-Zong
    Cancer Imaging.2024;[Epub]     CrossRef
  • Overdiagnosis of hepatocellular carcinoma: Prevented by guidelines?
    Nicole E. Rich, Amit G. Singal
    Hepatology.2022; 75(3): 740.     CrossRef
  • Chest radiography surveillance for lung cancer: Results from a National Health Insurance database in South Korea
    Hyun Jung Koo, Chang-Min Choi, Sojung Park, Han Na Lee, Dong Kyu Oh, Won-Jun Ji, Seulgi Kim, Mi Young Kim
    Lung Cancer.2019; 128: 120.     CrossRef
  • Proteomic Biomarkers for Bisphenol A–Early Exposure and Women’s Thyroid Cancer
    Ho-Sun Lee, Yunkyeong Kang, Kyung Tae, Gyu-Un Bae, Jong Y. Park, Yoon Hee Cho, Mihi Yang
    Cancer Research and Treatment.2018; 50(1): 111.     CrossRef
  • Lessons from Fukushima: Latest Findings of Thyroid Cancer After the Fukushima Nuclear Power Plant Accident
    Shunichi Yamashita, Shinichi Suzuki, Satoru Suzuki, Hiroki Shimura, Vladimir Saenko
    Thyroid.2018; 28(1): 11.     CrossRef
  • Defining, Estimating, and Communicating Overdiagnosis in Cancer Screening
    Louise Davies, Diana B. Petitti, Lynn Martin, Meghan Woo, Jennifer S. Lin
    Annals of Internal Medicine.2018; 169(1): 36.     CrossRef
  • Getting personal on overdiagnosis: On defining overdiagnosis from the perspective of the individual person
    Bjørn Hofmann
    Journal of Evaluation in Clinical Practice.2018; 24(5): 983.     CrossRef
  • The Use of International Classification of Diseases Codes to Identify Patients with Pancreatitis: A Systematic Review and Meta-analysis of Diagnostic Accuracy Studies
    Amy Y. Xiao, Marianne L. Tan, Maria N. Plana, Dhiraj Yadav, Javier Zamora, Maxim S. Petrov
    Clinical and Translational Gastroenterology.2018; 9(10): e191.     CrossRef
  • Overdiagnosis of thyroid cancer in the Marne and Ardennes Departments of France from 1975 to 2014
    Caroline Saint-Martin, Moustapha Dramé, Sandrine Dabakuyo, Lukshe Kanagaratnam, Patrick Arveux, Claire Schvartz
    Annales d'Endocrinologie.2017; 78(1): 27.     CrossRef
  • What Is the “Screening Effect” Six Years After the Fukushima Nuclear Power Plant Accident?
    Shunichi Yamashita, Vladimir A. Saenko
    Thyroid.2017; 27(5): 595.     CrossRef
  • Strategies for Appropriate Patient-centered Care to Decrease the Nationwide Cost of Cancers in Korea
    Jong-Myon Bae
    Journal of Preventive Medicine and Public Health.2017; 50(4): 217.     CrossRef
  • Overdiagnosis across medical disciplines: a scoping review
    Kevin Jenniskens, Joris A H de Groot, Johannes B Reitsma, Karel G M Moons, Lotty Hooft, Christiana A Naaktgeboren
    BMJ Open.2017; 7(12): e018448.     CrossRef
  • The impact of family history on non-medullary thyroid cancer
    I.J. Nixon, C. Suárez, R. Simo, A. Sanabria, P. Angelos, A. Rinaldo, J.P. Rodrigo, L.P. Kowalski, D.M. Hartl, M.L. Hinni, J.P. Shah, A. Ferlito
    European Journal of Surgical Oncology (EJSO).2016; 42(10): 1455.     CrossRef
  • Are Ocular and Ocular Adnexal Cancers Overdiagnosed? Historical Perspectives on Diagnosis
    Curtis E. Margo
    Cancer Control.2016; 23(2): 90.     CrossRef
  • Epidemiological evidences on overdiagnosis of prostate and kidney cancers in Korean
    Jong-Myon Bae
    Epidemiology and Health.2015; 37: e2015015.     CrossRef
  • Development and application of patient decision aids
    Jong-Myon Bae
    Epidemiology and Health.2015; 37: e2015018.     CrossRef
  • It needs adaptation to the 2015 Korean guideline for breast cancer screening
    Jong-Myon Bae
    Journal of the Korean Medical Association.2015; 58(9): 833.     CrossRef

Epidemiol Health : Epidemiology and Health